inositol has been researched along with Flatus in 3 studies
Inositol: An isomer of glucose that has traditionally been considered to be a B vitamin although it has an uncertain status as a vitamin and a deficiency syndrome has not been identified in man. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1379) Inositol phospholipids are important in signal transduction.
inositol : Any cyclohexane-1,2,3,4,5,6-hexol.
1D-chiro-inositol : Belonging to the inositol family of compounds, D-chiro-inositol (DCI) is an isomer of glucose. It is an important secondary messenger in insulin signal transduction.
muco-inositol : An inositol that is cyclohexane-1,2,3,4,5,6-hexol having a (1R,2R,3r,4R,5S,6r)-configuration.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Patients who received mesalamine plus the mixture of beta-glucan, inositol and digestive enzymes (group A) reported a reduction in abdominal pain together with reduction in bloating and flatulence after four weeks of treatment." | 9.24 | Beta-glucan, inositol and digestive enzymes improve quality of life of patients with inflammatory bowel disease and irritable bowel syndrome. ( Cosco, C; Cosco, V; Doldo, P; Garieri, P; Mancina, RM; Ruggiero, G; Spagnuolo, R, 2017) |
| "Patients who received mesalamine plus the mixture of beta-glucan, inositol and digestive enzymes (group A) reported a reduction in abdominal pain together with reduction in bloating and flatulence after four weeks of treatment." | 5.24 | Beta-glucan, inositol and digestive enzymes improve quality of life of patients with inflammatory bowel disease and irritable bowel syndrome. ( Cosco, C; Cosco, V; Doldo, P; Garieri, P; Mancina, RM; Ruggiero, G; Spagnuolo, R, 2017) |
| "A total of 21 inpatients with type 2 diabetes were recruited to a single-center, 2-period, crossover trial." | 1.33 | Effect of two alpha-glucosidase inhibitors, voglibose and acarbose, on postprandial hyperglycemia correlates with subjective abdominal symptoms. ( Fujisawa, T; Ikegami, H; Inoue, K; Kawabata, Y; Ogihara, T, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Spagnuolo, R | 1 |
| Cosco, C | 1 |
| Mancina, RM | 1 |
| Ruggiero, G | 1 |
| Garieri, P | 1 |
| Cosco, V | 1 |
| Doldo, P | 1 |
| Ciacci, C | 1 |
| Franceschi, F | 1 |
| Purchiaroni, F | 1 |
| Capone, P | 1 |
| Buccelletti, F | 1 |
| Iacomini, P | 1 |
| Ranaudo, A | 1 |
| Andreozzi, P | 1 |
| Tondi, P | 1 |
| Gentiloni Silveri, N | 1 |
| Gasbarrini, A | 1 |
| Gasbarrini, G | 1 |
| Fujisawa, T | 1 |
| Ikegami, H | 1 |
| Inoue, K | 1 |
| Kawabata, Y | 1 |
| Ogihara, T | 1 |
2 trials available for inositol and Flatus
| Article | Year |
|---|---|
Beta-glucan, inositol and digestive enzymes improve quality of life of patients with inflammatory bowel disease and irritable bowel syndrome.
Topics: Abdominal Pain; Anti-Inflammatory Agents, Non-Steroidal; beta-Glucans; Biological Factors; Drug Comb | 2017 |
Effect of beta-glucan, inositol and digestive enzymes in GI symptoms of patients with IBS.
Topics: Abdominal Pain; Adult; Aged; beta-Glucans; Drug Combinations; Enzyme Therapy; Enzymes; Female; Flatu | 2011 |
1 other study available for inositol and Flatus
| Article | Year |
|---|---|
Effect of two alpha-glucosidase inhibitors, voglibose and acarbose, on postprandial hyperglycemia correlates with subjective abdominal symptoms.
Topics: Acarbose; Aged; Blood Glucose; Cross-Over Studies; Diabetes Mellitus, Type 2; Enzyme Inhibitors; Fem | 2005 |